middle.news
OncoSil Medical Raises $8M to Accelerate Pancreatic Cancer Device Rollout
11:12am on Tuesday 3rd of February, 2026 AEDT
•
Healthcare
Read Story
OncoSil Medical Raises $8M to Accelerate Pancreatic Cancer Device Rollout
11:12am on Tuesday 3rd of February, 2026 AEDT
Key Points
Equity raise of $8 million via $6 million placement and $2 million entitlement offer
OncoSil device approved in over 34 countries, targeting pancreatic cancer
Clinical trials PANCOSIL and TRIPP-FFX completed recruitment, data expected in 2026
New Sydney manufacturing facility supports potential $98 million revenue at 70% gross margin
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE